European Stocks Dip Oil Prices Surge After US Military Strikes Iran Chinas Big Three Airlines Face Steeper Challenges Amid High Jet Fuel Costs and Rail Competition Pope Leo XIVs AI Encyclical Sparks Ethics Debate Potentially Shaping Tech Regulation Landscape Bitcoin Slips Below 76000 Poised for Weekly Decline Amid Liquidations and Interest Rate Volatility US Races to Establish Ebola Quarantine Facility in Kenya Implications for Global Health Security and Markets Indian Government in Advanced Consultations on Cotton Import Duty Removal Official Says SEB Q1 2026 Earnings Strong EPS Performance Amid Limited Visibility Haverty Furniture HVT Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Higher Equity Lifestyle Properties Inc ELS Q1 2026 Earnings Modest EPS Beat Amid Stable Operations SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports a Surprising Profit PAPL Q3 2025 Earnings EPS Surprises Positively Despite Revenue Uncertainty Stock Declines PENG Q1 2026 Earnings EPS Beats Estimates by 2065 Shares Surge FuelCell Energy FCEL Edges Higher as Key Resistance Test Looms VivoSim Labs VIVS Dips Slightly as Stock Tests Key Support Levels Federal Realty Trust Edges Higher Amid Steady REIT Sector JAKKS Pacific JAKK Holds Steady Near Support as Traders Eye Resistance Levels Kinetik Holdings KNTK Slips 287 Support Test Looms as Energy Midstream Faces Pressure Housing and Climate Resilience Top Latin American Agenda at World Urban Forum 13 JBGS Q1 2026 Earnings Positive EPS Reported Amidst Limited Guidance Nextdoor Holdings NXDR Slips Near Support as Trading Volatility Persists M Evo Global Acquisition Corp II Warrants MEVOW Holds Steady at 039 as Warrants Trade Near Support GreenTree Hospitality GHG Climbs 536 as Bulls Target 124 Resistance TORM plc TRMD Declines 284 as Selling Pressure Tests Key Support Zone Millennium Group International MGIH Edges Lower Amidst Consolidation Near Key Support Kodiak Gas Services KGS Gains 182 as Support Holds Resistance Looms KalVista Pharmaceuticals KALV Holds Steady Near Support After Modest Gain Sarepta Therapeutics SRPT Edges Higher Amid Modest Gains